Establishment of cancer/testis antigen profiling based on clinicopathological characteristics in resected pathological stage III non-small cell lung cancer

BACKGROUND: Cancer/testis antigen (CTA) expression was found to be highly heterogeneous in previous studies. We aimed to establish a precision CTA profiling in resected stage III non-small cell lung cancer (NSCLC) and demonstrate the best CTA combination covering the widest range of NSCLC cases. MAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Shi, Cao, Shoubo, Grigorev, Aleksei, Li, Jianhua, Meng, Qingwei, Wang, Chunyan, Feng, Meiyan, Hu, Jing, Jiang, Feng, Yu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053259/
https://www.ncbi.nlm.nih.gov/pubmed/30038519
http://dx.doi.org/10.2147/CMAR.S164043

Ejemplares similares

Ejemplares similares